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In December 2019 a new form of pneumonia was observed in the Chinese province 15 
of Hubei.[1] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 16 
was subsequently identified as responsible of this condition, defined coronavirus 17 
disease (COVID-19).[2] The virus has now spread outside Chinese borders with 18 
82,297 cases and 2,804 deaths worldwide at the 26th of February.[3] After infection, 19 
symptoms appear after an incubation time of 3-5 days, with 80% of those infected 20 
developing a mild disease, 15% a severe disease and 5% will require support in 21 
intensive care unit (ICU).[4] Overall, the estimated case-fatality rate is comprised 22 
between 0.4% and 2.9% and the basic reproduction number is approximately 23 
3.28.[4,5] SARS-CoV-2 is a new pathogen for humankind and any type of immune 24 
protection exist, thus everybody can be potentially infected. Moreover, no primary 25 
prophylaxis measures (vaccination) nor effective treatments are available. If the 26 
above represented percentages are applied to the worldwide populations, it appears 27 
clear why any measure should be considered to avoid a further diffusion of the virus 28 
and prevent the saturation and collapse of health systems and the most catastrophic 29 
pandemic since 1919 Spanish flu. 30 
Isolation of those affected and the use of personal protective equipment (PPE) are 31 
the mainstay to block transmission of this pathogen, which is presumed through 32 
respiratory droplets. A 14 days quarantine is applied to subjects coming from 33 
endemic areas or who had contact with confirmed cases. It is assumed that, if in this 34 
period the subject does not develop any sign or symptoms compatible with COVID-35 
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19, he is not infected and thus the quarantine can be removed, and the subject 36 
returned to the community. Domiciliary quarantine of 14 days since a positive test is 37 
applied also for patients with a diagnosed mild disease who did not need medical 38 
support.  39 
These rules are effective in controlling infections in the community, but several 40 
doubts arise when it is necessary to transpose them in the hospital setting. Hospitals 41 
are indeed a delicate place in epidemics: they collect fragile persons who can be 42 
exposed to the virus and are subsequently readmitted to the community thus 43 
spreading the infection. Indeed, the ongoing outbreak in Northern Italy has been 44 
linked to a single infected patient who accessed to a community hospital where he 45 
transmitted the virus to several other patients and health-care operators.[6] 46 
Moreover, the isolation of patients in the hospital setting impose a significant burden 47 
in terms of PPE used by the health-care operators, space dedicated and time 48 
employed in their management. Even more complex is the situation of patients in 49 
ICU, where viral spreading is facilitated by endotracheal tubes and manoeuvres 50 
performed on the respiratory tract. Therefore, a clear definition of the infectiousness 51 
timing and intensity of viral spreading is mandatory to alleviate the burden on the 52 
health-care system.  53 
Unfortunately, the data available on the topic are scarce and composed only of 54 
measurements of viral shedding, without an assessment of the infectivity. Kim et 55 
al.[7] assessed the viral load kinetics of SARS-CoV-2 in upper and lower respiratory 56 
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tract materials in the first two confirmed patients in Korea. They employed real-time 57 
reverse transcriptase polymerase chain reaction (rRT-PCR) to detect SARS-CoV-2 58 
and converted cycle threshold (CT) values of rRT-PCR into RNA copy number. The 59 
detection limit of rRT-PCR was 2,690 copies/mL. Overall, viral load above detection 60 
limit was detected until 14 and 25 days after symptoms onset and for 13 and 11 days 61 
after the first detection, respectively.[7] Of note, both patients received treatment 62 
with lopinavir/ritonavir. Instead, Zou and colleagues analysed viral load in repeated 63 
nasal and throat swabs obtained from the 17 symptomatic patients.[8] They also 64 
employed rRT-PCR and considered a CT of 40 as detection limit. Higher viral loads 65 
were observed in nasal swabs and in samples collected soon after symptoms onset. 66 
Overall, only two patients presented positive samples, and only in nasal swab, 14 67 
days after symptoms onset, and with low viral load.   68 
In conclusion, a larger amount of data about duration of viral spreading and 69 
infectivity in hospitalized patients, especially in ICU, is badly needed to better define 70 
quarantine period and avoid nosocomial transmission. Before their availability, the 71 
canonical 14 days period of quarantine should be respected.  72 
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